Alcon vs Zimmer Biomet
Alcon is the larger business, with $10.40bn of revenue in fiscal 2025 against $8.23bn for Zimmer Biomet (1.3 times as much). Zimmer Biomet grew faster (7.2% against 4.9%). Alcon kept more of each dollar of sales as profit: a net margin of 9.4% against 8.6%.
| Latest fiscal year | AlconALC, 2025 | Zimmer BiometZBH, 2025 |
|---|---|---|
| Revenue | $10.40bn | $8.23bn |
| Revenue growth | 4.9% | 7.2% |
| Net income | $980m | $705m |
| Operating margin | 13.1% | — |
| Net margin | 9.4% | 8.6% |
| Return on equity | 4.5% | 5.6% |
| Free cash flow | $1.73bn | $1.47bn |
| Cash | $1.53bn | $592m |
| Total debt | $4.74bn | $7.52bn |
| Debt to equity | 21.5% | — |
| Dividend per share | — | $0.96 |
| Dividend yield | 0.5% | 1.0% |
| Share buybacks | $676m | $487m |
| Employees | — | 17,000 |
| Market value | $36.00bn | $18.64bn |
| Price vs our value range | Within our value range | Within our value range |
| Moat score | — | 71 (Strong) |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 6 sales |